Summary
Elevance Health, Inc. (ELV), formerly WellPoint, Inc., issued this Form 8-K on September 10, 2010, to disclose that its officers would be meeting with securities analysts and investors from September 13 to September 24, 2010. During these meetings, the company planned to reaffirm its full-year 2010 earnings per share (EPS) guidance, which was initially provided on July 28, 2010. This guidance assumed no significant net investment gains or losses or asset impairment charges beyond those already recorded in the first and second quarters, and was contingent upon the company's ability to secure and maintain adequate premium rates. The filing also included a standard safe harbor statement under the Private Securities Litigation Reform Act of 1995, outlining forward-looking statements and the various risks and uncertainties that could cause actual results to differ from projections. Key risk factors mentioned include increasing government regulation (particularly the impact of the Affordable Care Act), healthcare cost trends, premium rate approvals, competition, enrollment trends, Medicare and Medicaid program risks, and potential impacts from the Express Scripts transaction.
Key Highlights
- 1WellPoint, Inc. (now Elevance Health) reaffirms full-year 2010 EPS guidance during analyst and investor meetings.
- 2The reaffirmed guidance excludes significant net investment gains/losses or asset impairment charges beyond Q1 and Q2 2010.
- 3Guidance is conditional on the company's ability to secure and maintain sufficient premium rates.
- 4The report includes forward-looking statements and a detailed safe harbor statement identifying potential risks.
- 5Key risks mentioned include regulatory changes (Affordable Care Act), healthcare cost trends, and competitive pressures.
- 6Potential impacts from the Express Scripts transaction are cited as a risk factor.